TFPI2 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a full length recombinant TFPI2.
|Application ||WB, IHC, E|
|Calculated MW||26934 Da|
|Other Names||Tissue factor pathway inhibitor 2, TFPI-2, Placental protein 5, PP5, TFPI2|
|Target/Specificity||TFPI2 (AAH05330, 1 a.a. ~ 235 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||TFPI2 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Tissue factor pathway inhibitor-2 is induced by fluid shear stress in vascular smooth muscle cells and affects cell proliferation and survival. Ekstrand J, et al. J Vasc Surg, 2010 Jul. PMID 20537494.Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer. Hibi K, et al. Anticancer Res, 2010 Apr. PMID 20530429.A novel role for tissue factor pathway inhibitor-2 in the therapy of human esophageal carcinoma. Ran Y, et al. Hum Gene Ther, 2009 Jan. PMID 20377370.Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma. Ribarska T, et al. Cancer Genomics Proteomics, 2010 Mar-Apr. PMID 20335518.Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Takada H, et al. Cancer Genet Cytogenet, 2010 Feb. PMID 20113832.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.